Tudor Investment Corp’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-85,609
| Closed | -$2.54M | – | 2912 |
|
|
2023
Q4 | $2.54M | Buy |
+85,609
| New | +$1.7M | 0.02% | 984 |
|
|
2022
Q4 | – | Sell |
-87,428
| Closed | -$418K | – | 2961 |
|
|
2022
Q3 | $418K | Sell |
87,428
-232,719
| -73% | -$1.23M | 0.01% | 1527 |
|
|
2022
Q2 | $1.44M | Sell |
320,147
-254,522
| -44% | -$1.11M | 0.04% | 675 |
|
|
2022
Q1 | $2.73M | Buy |
574,669
+32,361
| +6% | +$179K | 0.06% | 408 |
|
|
2021
Q4 | $4.02M | Buy |
542,308
+58,318
| +12% | +$362K | 0.07% | 342 |
|
|
2021
Q3 | $2.74M | Buy |
483,990
+99,197
| +26% | +$573K | 0.04% | 532 |
|
|
2021
Q2 | $2.54M | Buy |
384,793
+310,721
| +419% | +$2.17M | 0.05% | 464 |
|
|
2021
Q1 | $600K | Buy |
+74,072
| New | +$605K | 0.01% | 1067 |
|
|
2020
Q4 | – | Sell |
-277,460
| Closed | -$999K | – | 1700 |
|
|
2020
Q3 | $999K | Buy |
277,460
+212,923
| +330% | +$860K | 0.04% | 566 |
|
|
2020
Q2 | $297K | Buy |
+64,537
| New | +$274K | 0.01% | 889 |
|
|
2018
Q1 | – | Sell |
-18,321
| Closed | -$117K | – | 1307 |
|
|
2017
Q4 | $117K | Buy |
+18,321
| New | +$113K | ﹤0.01% | 1019 |
|
|
2017
Q2 | – | Sell |
-24,493
| Closed | -$95K | – | 1443 |
|
|
2017
Q1 | $95K | Sell |
24,493
-8,387
| -26% | -$24.5K | ﹤0.01% | 1311 |
|
|
2016
Q4 | $67K | Buy |
32,880
+2,631
| +9% | +$5.28K | ﹤0.01% | 1328 |
|
|
2016
Q3 | $81K | Sell |
30,249
-33,051
| -52% | -$96.1K | ﹤0.01% | 1352 |
|
|
2016
Q2 | $195K | Buy |
+63,300
| New | +$397K | ﹤0.01% | 1415 |
|
Other funds holding IMGN
Tudor Investment Corp's IMGN Position: Q1 2024 in Review
Tudor Investment Corp sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 85,609 shares — an estimated $2.54M sold.
Tudor Investment Corp first reported a position in IMGN in Q2 2016 and held it in 15 quarters. The position peaked at $4.02M in Q4 2021. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Tudor Investment Corp reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Tudor Investment Corp sold 85,609 Immunogen Inc shares in Q1 2024, an estimated $2.54M.
- Tudor Investment Corp first reported a position in Immunogen Inc in Q2 2016 and held it in 15 quarters.
- Tudor Investment Corp's Immunogen Inc position peaked at $4.02M in Q4 2021.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Tudor Investment Corp's 13F filing for Q1 2024, filed 15 May 2024.